Real world embedding
close
프로필 배경
프로필 로고

Real world embedding

  • 분류 전체보기 (422)
    • devOps (5)
    • Pharmacology (411)
      • News (8)
      • BS (402)
  • 홈
  • BS
  • devOps

Rosalind Franklin University Researcher Awarded NIH Funding to Investigate Links Between Down Syndrome and Alzheimer's Disease

Rosalind Franklin University researcher, Dr. Grace E. Stutzmann, has been granted $1.8 million by the National Institute on Aging to investigate the connection between Down Syndrome and Alzheimer's disease. This research collaboration with New York University aims to develop new therapeutic strategies for individuals with Down Syndrome who are at risk of developing Alzheimer's. Down Syndrome is ..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 26.
  • textsms

UMCG in the Netherlands Purchases Micro-RayStation for Pre-Clinical Research

UMCG in the Netherlands has recently acquired Micro-RayStation, a research software platform developed by RaySearch Laboratories. This software is specifically designed for pre-clinical research involving radiation treatment planning and plan evaluation in small animals. RaySearch Laboratories AB (publ) has announced that University Medical Center Groningen (UMCG) in the Netherlands has placed a..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 10.
  • textsms

City of Hope Presents New Research on Beta Cells, Insulin Secretion, and Islet Transplantation at ADA Conference

City of Hope, one of the largest cancer research and treatment organizations in the United States, presented new research on beta cells, insulin secretion, and islet transplantation at the annual American Diabetes Association (ADA) Conference. The research aims to improve understanding of type 1 and type 2 diabetes and enhance treatment options. The studies conducted by City of Hope scientists f..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 6. 28.
  • textsms

NRx Pharmaceuticals Announces Closing of $6.28 Million Registered Direct Offering

NRx Pharmaceuticals has announced the completion of its registered direct offering for 9,670,002 shares of common stock at $0.65 per share, resulting in gross proceeds of approximately $6.28 million before deducting placement agent fees and other expenses. The company intends to use net proceeds from the offering for working capital and general corporate purposes, as well as potentially using it..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 6. 11.
  • textsms
  • navigate_before
  • 1
  • navigate_next
공지사항
  • 데이터 요청 관련 문의
전체 카테고리
  • 분류 전체보기 (422)
    • devOps (5)
    • Pharmacology (411)
      • News (8)
      • BS (402)
최근 글
인기 글
최근 댓글
태그
  • #Safety
  • #cancer
  • #N/A
  • #fda
  • #Phase 3
  • #Clinical Trial
  • #FDA approval
  • #Study
  • #astrazeneca
  • #Trial
전체 방문자
오늘
어제
전체
Copyright © 쭈미로운 생활 All rights reserved.
Designed by JJuum

티스토리툴바